Aspirin Dose Increase from 75 to 150 mg Suppresses Red Blood Cell Contribution to Suboptimal Platelet Response to Aspirin in Patients with CAD

Author： Karolczak Kamil   Pietruszynski Robert   Drzewoski Jozef   Kasznicki Jacek   Watala Cezary  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.27, Iss.6, 2013-12, pp. : 549-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin suppresses platelet reactivity in both sexes

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events

By  

Heart Drug, Vol. 2, Iss. 2, 2002-06 ,pp. : 93-104

Karger

Access to resources Recommend Favorite

Non-aspirin NSAIDs increase risk of renal cell cancer

By  

Reactions Weekly, Vol. 1, Iss. 1371, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Discharge aspirin dose may affect clinical course in patients with ACS

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Aspirin + clopidogrel superior for platelet inhibition

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite